GUJARAT THEMIS BIOSYN LTD Share Price

₹ 372.10

+₹8.90 (2.45%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: GUJTHEM
|
Pharmaceuticals

GUJARAT THEMIS BIOSYN LTD Share Price Today

As of 3 Nov 2026, GUJARAT THEMIS BIOSYN LTD share price is ₹372.10. The stock opened at ₹363.20, compared to its previous close of ₹363.20. During today's trading session, GUJARAT THEMIS BIOSYN LTD share price moved in the range of ₹362.35 to ₹380.50, with an average price of ₹371.43 for the day. Looking at its last 52-week, the stock has touched a low of ₹225.05 and a high of ₹471.80. On the performance front, GUJARAT THEMIS BIOSYN LTD share price has increased by 1.67% over the last six months and is down 20.52% on a year-on-year basis.

Share price over the last 1 day rose from 364.20 to 372.10, ranging between 363.20 and 380.05.
₹362.35
2.45% up today
₹380.50
1D LOW
1D HIGH

GUJARAT THEMIS BIOSYN LTD Stock Insights

Latest Earning
Op Profit TrendUp by 5.79% QoQ
Latest Earning
Net Profit TrendUp by 1.65% QoQ
Latest Earning
Revenue TrendDown by 2.72% QoQ
Stock Performance
OutperformingBeat Nifty by 6.9 % in last 3 month
Shareholding Pattern
DIIDII decreased stake by 27.02%
Shareholding Pattern
FIIFII decreased stake by 22.97%
GUJARAT THEMIS BIOSYN LTD stock performance
Open₹363.20
High₹380.50
Low₹362.35
Prev. close₹363.20
GUJARAT THEMIS BIOSYN LTD trading activity
Volume1,17,043
Average traded price₹373.02
Last traded time03:29:42 02 Nov
Last traded quantity50
Circuit
L
H
₹295.75
₹443.55
52-week
L
H
₹225.05
₹471.80
Mkt Cap Cr
4,718.00
P/E
96.93
P/B
4.55
ROA
9.67%
ROE
16.22%
ROCE
14.47%
Quick Ratio
0.93
EV/EBITDA
57.66

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Guj. Themis Bio. has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Guj. Themis Bio. appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Guj. Themis Bio. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,74,402.4783.099.494.7%11.42%11.37%0.7533.6
Laurus Labs1,26,811.2895.1720.9211.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

GUJARAT THEMIS BIOSYN LTD Company Background

ISIN
INE942C01045
Sector Market Cap
₹ 4,718.00 Cr

Gujarat Themis Biosyn Limited is an India-based company, which is principally engaged in the manufacturing of pharmaceuticals and medicinal chemical products. The Company is focused on the business of manufacturing and sale of finished active pharmaceutical ingredients (API) products by fermentation process. The Company operates through pharmaceuticals segment. Its product portfolio comprises Rifamycin-S and Lovastatin. The Company is manufacturing Rifamycin S, which is an intermediate for manufacturing the drug Rifampicin (an Antibiotic used for the treatment of several types of bacterial infections, including tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease.) and Rifamycin O, which is an intermediate for manufacturing the drug Rifaximin (this is an Antibiotic used for treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy).

GUJARAT THEMIS BIOSYN LTD Financial Highlights

  • Revenue: GUJARAT THEMIS BIOSYN LTD reported revenue of ₹168.25 crore in FY26 vs ₹153.23 crore in FY25. It showed an increase of 9.80% on a yearly basis.
  • Operating Profit: GUJARAT THEMIS BIOSYN LTD reported an operating profit of ₹62.09 crore in FY26 vs ₹65.54 crore in FY25. It showed a decrease of 5.26% on a year-on-year basis.
  • Net Profit: GUJARAT THEMIS BIOSYN LTD reported a net profit of ₹46.68 crore in FY26 vs ₹48.77 crore in FY25. It showed a decrease of 4.29% on a yearly basis.

GUJARAT THEMIS BIOSYN LTD Quarterly Result Highlights

  • GUJARAT THEMIS BIOSYN LTD reported revenue of ₹43.92 crore in Jun 2026, compared with ₹45.15 crore in Mar 2026, representing a decrease of 2.72% on a quarter-on-quarter (QoQ) basis.
  • GUJARAT THEMIS BIOSYN LTD reported an operating profit of ₹15.17 crore in Jun 2026, compared with ₹14.34 crore in Mar 2026, representing an increase of 5.79% on a quarter-on-quarter (QoQ) basis.
  • GUJARAT THEMIS BIOSYN LTD reported a profit of ₹11.07 crore in Jun 2026, compared with ₹10.89 crore in Mar 2026, reflecting an increase of 1.65% on a QoQ basis.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
59.33%
FII
3.80%
Other DII
3.02%
Retail and other
24.22%
Mutual funds
9.63%
Foreign Institutional Investor (FII)
FII shareholding by period
Mar 20261.80%
Jun 20261.77%
Aug 20264.93%
Sep 20263.80%

GUJARAT THEMIS BIOSYN LTD Investment Returns

1 day
+1.78%
1 week
+9.40%
1 month
-3.18%
1 year
-20.52%
3 years
+51.83%
5 years
+51.83%

GUJARAT THEMIS BIOSYN LTD Share Price History

GUJARAT THEMIS BIOSYN LTD share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
02 Nov 26
₹363.20 / ₹369.65
+1.78%
30 Oct 26
₹375.80 / ₹363.20
-3.35%
29 Oct 26
₹353.00 / ₹375.80
+5.70%
28 Oct 26
₹345.15 / ₹355.55
+0.84%
Show more

GUJARAT THEMIS BIOSYN LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026
Revenue168.25
Operating profit62.09
Net profit46.68

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹165.82₹150.80₹169.82₹148.39
Other Income₹2.43₹1.67₹4.37₹6.59
Total Revenue₹168.25₹152.47₹174.19₹154.97
Total Expenses₹106.16₹86.94₹94.85₹77.51
Profit Before Tax₹62.09₹65.54₹79.33₹77.46
Tax₹15.41₹16.77₹20.17₹19.50
Profit After Tax₹46.68₹48.77₹59.16₹57.97
EPS - Basic₹4.28₹4.48₹40.72₹39.90
EPS - Diluted₹4.28₹4.48₹40.72₹39.90

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹62.09₹65.54₹79.33₹77.46
Income before WC changes₹77.31₹70.63₹79.80₹75.01
Change in Assets-₹20.50₹35.41₹3.82-₹15.64
Change in Liabilities₹2.61₹1.47₹0.38₹0.53
Change in WC-₹17.88₹36.88₹4.19-₹15.11
Cash flow from Operations₹48.78₹91.03₹64.21₹39.48
Cash flow from Investing-₹172.28-₹111.82-₹55.21-₹20.41
Cash flow from Financing₹114.93₹26.01-₹8.59-₹13.27
Total Cash Flow-₹8.57₹5.22₹0.41₹5.79
Cash (Start of the year)₹11.69₹6.47₹6.06₹0.26
Cash (End of the year)₹3.12₹11.69₹6.47₹6.06

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹414.64₹249.34₹173.55₹104.60
Current Assets₹88.78₹51.97₹47.56₹61.73
Total Assets₹503.43₹301.31₹221.11₹166.33
Current Liabilities₹79.15₹20.56₹16.16₹15.28
Net Current Asset₹9.64₹31.41₹31.40₹46.45
Non-Current Liabilities₹136.51₹32.37₹3.58₹1.90
Equity Capital₹287.77₹248.38₹201.38₹149.15
Total Equity & Liabilities₹503.43₹301.31₹221.11₹166.33
* All values are in INR Crore
GUJARAT THEMIS BIOSYN LTD market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
GUJARAT THEMIS BIOSYN LTD technical summary
Bearish indicators3
Neutral indicators5
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
47.02
Neutral
ATR (14)
22.74
Neutral
STOCH(9,6)
67.47
Neutral
STOCH RSI (14)
80.35
Bearish
ADX(9)
30.87
Bearish
UO(9)
54.29
Neutral
ROC(12)
-2.63
Bearish
WillR(14)
-38.06
Neutral
Period
Simple value
Exponential vaue
5D
357.01
360.15
10D
354.55
359.69
20D
365.29
367.31
50D
393.85
379.21
100D
383.18
377.01
Volume trend — traded volume by day
2 Nov1L
30 Oct1L
29 Oct2L
28 Oct1L
27 Oct1L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

GUJARAT THEMIS BIOSYN LTD
Pharmaceuticals
Add Stock
Add Another

GUJARAT THEMIS BIOSYN LTD Returns Calculator

Ex-date: 23 Sep 2026

Top Gainers

ITI Share Price
₹259.14
+43.19 (+20%)
ENGINERSIN Share Price
₹289.65
+37.8 (+15.01%)
AFFLE Share Price
₹1506.50
+164.7 (+12.27%)
PRAJIND Share Price
₹271.13
+29.43 (+12.18%)
DIXON Share Price
₹12319.00
+1319 (+11.99%)
See more

Top Losers

INDIGOPNTS Share Price
₹870.00
-127.3 (-12.76%)
CLEAN Share Price
₹662.60
-53 (-7.41%)
ZEEL Share Price
₹61.58
-4.82 (-7.26%)
SYRMA Share Price
₹1512.00
-113.3 (-6.97%)
POLICYBZR Share Price
₹931.00
-69.1 (-6.91%)
See more

GUJARAT THEMIS BIOSYN LTD Share Price FAQs

Please be aware that GUJARAT THEMIS BIOSYN LTD stock prices are subject to continuous fluctuations due to various factors.